Short-term surgical complications of skin-sparing mastectomy and direct-to-implant immediate breast reconstruction in women concurrently treated with adjuvant radiotherapy for breast cancer (2022; archives of plastic surgery (aps))

Autor: M. Kooijman, J.J. Hage, A. Scholten, M.J. Vrancken Peeters, L. Woerdeman

Publikováno v: European Journal of Cancer. 175:S20-S21

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4076c8ad63f6047bdc08e20195c0a8c0
https://doi.org/10.1016/s0959-8049(22)01399-5

Surgical outcomes after neoadjuvant systemic therapy in patients with lobular carcinoma

Autor: A. Van Hemert, A. van Loevezijn, A. Bosman, M.J. Vrancken Peeters, F. van Duijnhoven, I. van der Ploeg

Publikováno v: European Journal of Cancer. 175:S17

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::24868eecacf72691ced3bbf68f347044
https://doi.org/10.1016/s0959-8049(22)01390-9

Tailored axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer patients is safe: 3-year follow-up of the MARI protocol

Autor: A. Van Loevezijn, M.J. Vrancken-Peeters, C. Loo, Emma J. Groen, Nicola S. Russell, P. Elkhuizen, F. van Duijnhoven, Marcel P. M. Stokkel, M.E.M. van der Noordaa

Publikováno v: European Journal of Cancer. 138:S3-S4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ea4e845a7b262de2dbb1b3f63975f366
https://doi.org/10.1016/s0959-8049(20)30538-4

Direct or delayed oncoplastic reconstruction after wide local excision for breast cancer in breast conserving therapy: A single centre cohort study of 252 cases

Autor: C.S. Geluk, A. Van Loevezijn, F. van Duijnhoven, M.J. Hoornweg, M.J. Vrancken-Peeters

Publikováno v: European Journal of Cancer. 138:S48-S49

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b3ce338d9c74b14041f00e1091e82347
https://doi.org/10.1016/s0959-8049(20)30653-5

The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure

Autor: M.J. Vrancken Peeters, Sjoerd Rodenhuis, E. van Werkhoven, Gabe S. Sonke, Sabine C. Linn, Esther H. Lips, Claudette E. Loo, Jelle Wesseling, M. Jebbink, C. Falo Zamora, I.A.M. Mandjes

Publikováno v: Breast cancer research and treatment, 153(1), 145-152. Springer New York
Breast Cancer Research and Treatment, 153(1), 145. Springer New York

The Neoadjuvant response index (NRI) has been proposed as a simple measure of downstaging by neoadjuvant treatment in breast cancer. It was previously found to predict recurrence-free survival (RFS) in triple-negative (TN) breast cancer. It was at le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce15de213f897e2d846407c3155773aa
https://doi.org/10.1007/s10549-015-3510-4